Australia markets closed

Marinus Pharmaceuticals, Inc. (MRNS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.4600+0.2450 (+7.62%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.2150
Open3.3401
Bid3.4800 x 1800
Ask3.5400 x 1000
Day's range3.1100 - 3.6850
52-week range1.0100 - 4.0700
Volume7,484,573
Avg. volume4,811,460
Market cap422.826M
Beta (5Y monthly)1.99
PE ratio (TTM)N/A
EPS (TTM)-0.9680
Earnings date06 Aug 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.25
  • Why Marinus Pharmaceuticals Stock Skyrocketed 80% Higher Today
    Motley Fool

    Why Marinus Pharmaceuticals Stock Skyrocketed 80% Higher Today

    Investors are thrilled with the results from a late-stage clinical study of the company's only pipeline drug candidate.

  • Nasdaq Rises Despite Nikola Hit; Marinus Soars
    Motley Fool

    Nasdaq Rises Despite Nikola Hit; Marinus Soars

    Many investors have been worried about the Nasdaq Composite (NASDAQINDEX: ^IXIC) lately. The index has taken a leadership role during 2020's huge rebound from the coronavirus bear market, but its steep decline in early September made some believe that the best of times for the Nasdaq were now behind it. The Nasdaq gained more than 1% in early trading Tuesday, and helping to lead that charge was new enthusiasm about drugmaker Marinus Pharmaceuticals (NASDAQ: MRNS).

  • Marinus Pharmaceuticals (MRNS) Soars: Stock Adds 5.5% in Session
    Zacks

    Marinus Pharmaceuticals (MRNS) Soars: Stock Adds 5.5% in Session

    Marinus Pharmaceuticals (MRNS) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.